Tweet Archive for February 2019 « page 13

My selection of #AAD2019 posters – Readability and Literacy
P8648 – Quality, Reliability, Readability of Internet-S…

https://twitter.com/i/web/status/1100083248166854664

12:20pm Feb 25 2019 —

RT @ducrest: If you have interest in #rosacea and skin of color here an interesting open access JAAD article – Global epidemiology and clin…

7:49am Feb 25 2019 —

RT @ducrest: “Red Face” webinar imcas.com/en/academy/web…. We will discuss #rosacea diagnosis, botulinum toxin off label use and laser. Pls r…

7:49am Feb 25 2019 —

P8216 – Topical Delgocitinib (JTE-052), Janus Kinase Inhibitor, in Japanese Pediatric Patients with AD
P10021 – Dup…

https://twitter.com/i/web/status/1099784745548840960

in reply to ducrest — 4:34pm Feb 24 2019 —

P8673 – Treatment of AD w/ tapinarof cream
P8685 – Effects of Ruxolitinib Cream on Pruritus and Quality of Life in…

https://twitter.com/i/web/status/1099784741702778881

in reply to ducrest — 4:34pm Feb 24 2019 —

P9805 – Reasons for discontinuation of cyclosporine in AD patients in a community practice
P10231 – Mental health b…

https://twitter.com/i/web/status/1099784742885605376

in reply to ducrest — 4:34pm Feb 24 2019 —

P9720 – The impact of Socioeconomic Status in AD and how the internet can act as a public health intervention
P8542…

https://twitter.com/i/web/status/1099784744030650369

in reply to ducrest — 4:34pm Feb 24 2019 —

My selection of #AAD2019 posters – Atopic dermatitis (AD)
P8478 – Difamilast, a topical PDE4 inhibitor, a phase 2 s…

https://twitter.com/i/web/status/1099784739492384769

4:34pm Feb 24 2019 —

RT @LupusOrg: Study of #lupus subgroups underscores complexity of disease.

Read more. #LupusReserachNews

3:46pm Feb 24 2019 —

P10309 – Treatment with BIIB059, a monoclonal antibody targeting BDCA2, improves skin lesions in subjects w/ system…

https://twitter.com/i/web/status/1099772633456041985

in reply to ducrest — 3:46pm Feb 24 2019 —